Aurora Cannabis (TSE:ACB) Price Target Lowered to C$8.50 at ATB Capital

Aurora Cannabis (TSE:ACB) had its target price decreased by ATB Capital from C$11.00 to C$8.50 in a report published on Tuesday morning,BayStreet.CA reports.

Separately, TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of C$5.85.

Aurora Cannabis Price Performance

Aurora Cannabis stock opened at C$6.42 on Tuesday. The business has a 50-day simple moving average of C$6.94 and a 200 day simple moving average of C$7.58. Aurora Cannabis has a 52 week low of C$3.84 and a 52 week high of C$12.85. The stock has a market cap of C$350.92 million, a price-to-earnings ratio of -10.17 and a beta of 2.71. The company has a quick ratio of 2.48, a current ratio of 3.76 and a debt-to-equity ratio of 16.95.

Insider Transactions at Aurora Cannabis

In other Aurora Cannabis news, Senior Officer Andre Jerome sold 7,712 shares of the firm’s stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of C$7.70, for a total transaction of C$59,382.40.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.